Literature DB >> 10625135

Chronic Fatigue Syndrome and Primary Fibromyalgia Syndrome as recognized by GPs.

E Bazelmans1, J H Vercoulen, C M Swanink, J F Fennis, J M Galama, C van Weel, J W van der Meer, G Bleijenberg.   

Abstract

BACKGROUND: Prevalence studies on Chronic Fatigue Syndrome (CFS) are rare. Because of the similarity in symptoms, the prevalence of Primary Fibromyalgia Syndrome (PFS) was investigated at the same time.
OBJECTIVES: To determine the prevalence of CFS and PFS as recognized by GPs in The Netherlands and to inform them of the existence of CFS.
METHODS: A postal questionnaire was sent to all GPs.
RESULTS: The questionnaire was returned by 60% of the GPs. Seventy-three per cent reported one or more CFS patients and 83% one or more PFS patients in their practice.
CONCLUSION: The estimated prevalence of CFS as recognized by GPs of 112 (PFS 157) patients per 100,000 is a minimum estimate.

Entities:  

Mesh:

Year:  1999        PMID: 10625135     DOI: 10.1093/fampra/16.6.602

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  10 in total

1.  Vulvodynia: characteristics and associations with comorbidities and quality of life.

Authors:  Lauren D Arnold; Gloria A Bachmann; Raymond Rosen; Sarah Kelly; George G Rhoads
Journal:  Obstet Gynecol       Date:  2006-03       Impact factor: 7.661

2.  Using multiple sources of knowledge to reach clinical understanding of chronic fatigue syndrome.

Authors:  Carolyn A Chew-Graham; Greg Cahill; Christopher Dowrick; Alison Wearden; Sarah Peters
Journal:  Ann Fam Med       Date:  2008 Jul-Aug       Impact factor: 5.166

Review 3.  Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review.

Authors:  Kjetil Gundro Brurberg; Marita Sporstøl Fønhus; Lillebeth Larun; Signe Flottorp; Kirsti Malterud
Journal:  BMJ Open       Date:  2014-02-07       Impact factor: 2.692

4.  Identifying patients with medically unexplained physical symptoms in electronic medical records in primary care: a validation study.

Authors:  Madelon den Boeft; Johannes C van der Wouden; Trudie R Rydell-Lexmond; Niek J de Wit; Henriëtte E van der Horst; Mattijs E Numans
Journal:  BMC Fam Pract       Date:  2014-06-05       Impact factor: 2.497

Review 5.  A Literature Review of GP Knowledge and Understanding of ME/CFS: A Report from the Socioeconomic Working Group of the European Network on ME/CFS (EUROMENE).

Authors:  Derek F H Pheby; Diana Araja; Uldis Berkis; Elenka Brenna; John Cullinan; Jean-Dominique de Korwin; Lara Gitto; Dyfrig A Hughes; Rachael M Hunter; Dominic Trepel; Xia Wang-Steverding
Journal:  Medicina (Kaunas)       Date:  2020-12-24       Impact factor: 2.430

6.  Incidence of fatigue symptoms and diagnoses presenting in UK primary care from 1990 to 2001.

Authors:  Arlene M Gallagher; Janice M Thomas; William T Hamilton; Peter D White
Journal:  J R Soc Med       Date:  2004-12       Impact factor: 18.000

7.  Implementing cognitive behavior therapy for chronic fatigue syndrome in mental health care: a costs and outcomes analysis.

Authors:  Korine Scheeres; Michel Wensing; Gijs Bleijenberg; Johan L Severens
Journal:  BMC Health Serv Res       Date:  2008-08-13       Impact factor: 2.655

8.  Health-related quality of life in patients with myalgic encephalomyelitis/chronic fatigue syndrome: an Australian cross-sectional study.

Authors:  N Eaton-Fitch; S C Johnston; P Zalewski; D Staines; S Marshall-Gradisnik
Journal:  Qual Life Res       Date:  2020-01-22       Impact factor: 4.147

Review 9.  Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).

Authors:  Eun-Jin Lim; Yo-Chan Ahn; Eun-Su Jang; Si-Woo Lee; Su-Hwa Lee; Chang-Gue Son
Journal:  J Transl Med       Date:  2020-02-24       Impact factor: 5.531

10.  Nationwide epidemiological characteristics of chronic fatigue syndrome in South Korea.

Authors:  Eun-Jin Lim; Jin-Seok Lee; Eun-Jung Lee; Seok-Ju Jeong; Ho-Young Park; Yo-Chan Ahn; Chang-Gue Son
Journal:  J Transl Med       Date:  2021-12-07       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.